Xolair 150 MG/ML 1S
Ended Awarded
- Contract number
- SPE2DR26FBUFP
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,464
Award facts
- Contract value 100% obligated
- $24,464.16 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $24,464.16 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on June 2, 2026, for XOLAIR 150 mg/ml under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V).
PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical and medical consumable supply to Department of Defense military healthcare facilities worldwide. This delivery order is firm fixed price with place of performance in Park Ridge, Illinois. The order ultimate completion date is June 2, 2026.
Quick answers
Who was awarded contract SPE2DR26FBUFP?
SPE2DR26FBUFP was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 2, 2026.
How much is contract SPE2DR26FBUFP worth?
The government has obligated $24,464 on SPE2DR26FBUFP.
Is contract SPE2DR26FBUFP an order under another contract?
Yes. SPE2DR26FBUFP is a delivery order under SPE2DR25D9628, an indefinite delivery contract.
Was contract SPE2DR26FBUFP competed?
The extent of competition for SPE2DR26FBUFP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award